← Back to Patent Explorer
US4614796A Expired / Lapsed US ⏱️ 0.0 years remaining

Liposome and method of manufacture therefor

Assignee: Nippon Shinyaku Co Ltd
•
Filing: 1983-03-25
•
Granted: 1986-09-30
•
Expires: 2003-03-25
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Liposomes of steryl glucosides and/or steryl glucoside monopalmitates are useful for hemostatic, vascular stabilization and anti-shock effects, particularly in the form of injectable solutions.

Inventors

  • 👤 Masanobu Kawamata
  • 👤 Koichi Ushimaru
  • 👤 Shuji Yamane

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-26 17:24
CPC Classifications
C; C07; C07J; C07J17/00; C07J17/005; A; A61; A61K; A61K9/00; A61K9/10; A61K9/127; A61K9/1271; A61K9/1272

Claims Analysis

Total Claims: 16
Claim 1
Independent Claim 26 words
A liposome comprising a steryl glucoside and/or a steryl glucoside monopalmitate, water and a lipid selected from the group consisting of natural and synthetic phosphatidyl cholines.
Claim 2
Dependent Claim 26 words
A liposome comprising a steryl glucoside and/or a steryl glucoside monopalmitate, water and a lipid selected from the group consisting of natural and synthetic phosphatidyl cholines.
Claim 3
Dependent Claim 12 words
The liposome according to claim 1, in the form of simple lamella.
Claim 4
Dependent Claim 12 words
The liposome according to claim 1, in the form of multi-layered lamella.
Claim 5
Dependent Claim 15 words
The liposome according to claim 1, in which said natural phosphatidyl choline is yolk lecithin.
Claim 6
Dependent Claim 35 words
The liposome according to claim 1, in which said synthetic phosphatidyl choline is selected from the group consisting of dimyristoil phosphatidyl choline, dipalmitoyl phosphatidyl choline, distearyl phosphatidyl choline and dioleyl phosphatidyl choline and mixtures thereof.
Claim 7
Dependent Claim 18 words
The liposome according to claim 1, in which a sterol is included as a stabilizer for the liposome.
Claim 8
Dependent Claim 25 words
The liposome according to claim 6, in which said sterol is selected from the group consisting of cholesterol, β-sitosterol, stigmasterol and campesterol and mixtures thereof.
Claim 9
Dependent Claim 15 words
The liposome according to claim 1, including a charging agent that donates a positive charge.
Claim 10
Dependent Claim 17 words
The liposome according to claim 8, in which said charging agent donating a positive charge is stearylamine.
Claim 11
Dependent Claim 19 words
The liposome according to claim 1, in which the liposome contains a charging agent that donates a negative charge.
Claim 12
Dependent Claim 17 words
The liposome according to claim 10, in which the charging agent is phosphatidic acid or dicetylphosphoric acid.
Claim 13
Dependent Claim 38 words
The liposome according to claim 1, in which said steryl glucoside is selected from the group consisting of -β-sitosteryl-β-D-glucoside, stigmasteryl-β-D-glucoside, campesteryl-β-D-glucoside and cholesteryl-β-D-glucoside and a mixture thereof and said sterylglucoside monopalmitate is a monopalmitate of said steryl glucoside.
Claim 14
Dependent Claim 38 words
The liposome according to claim 1, in which said steryl glucoside is selected from the group consisting of -β-sitosteryl-β-D-glucoside, stigmasteryl-β-D-glucoside, campesteryl-β-D-glucoside and cholesteryl-β-D-glucoside and a mixture thereof and said sterylglucoside monopalmitate is a monopalmitate of said steryl glucoside.
Claim 15
Dependent Claim 38 words
The liposome according to claim 6, in which said steryl glucoside is selected from the group consisting of -β-sitosteryl-β-D-glucoside, stigmasteryl-β-D-glucoside, campesteryl-β-D-glucoside and cholesteryl-β-D-glucoside and a mixture thereof and said sterylglucoside monopalmitate is a monopalmitate of said steryl glucoside.
Claim 16
Dependent Claim 38 words
The liposome according to claim 8, in which said steryl glucoside is selected from the group consisting of -β-sitosteryl-β-D-glucoside, stigmasteryl-β-D-glucoside, campesteryl-β-D-glucoside and cholesteryl-β-D-glucoside and a mixture thereof and said sterylglucoside monopalmitate is a monopalmitate of said steryl glucoside.

References Cited (Backward Citations)

US3887698A Cited
US3991186A Cited
US4333926A Cited
US4129649A Cited
US4188379A Cited
US4193983A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1989-09-29 1990-03-31 1990-09-30 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1993-09-29 1994-03-31 1994-09-30 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1997-09-29 1998-03-31 1998-09-30 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag